GeneDx Holdings Corp. SEC filings WGS

GeneDx Holdings Corp. has 781 filings in SEC EDGAR's recent list, going back to Jul 23, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (results of operations). The company's fiscal year ends on December 31.

GeneDx Holdings Corp. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
25-NSE Delisting notice Jul 21, 2026 —
8-K Current report
Shareholder vote results
Jun 23, 2026 Jun 18, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 16, 2026 Jun 15, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Dec 31, 2025
8-K Current report
Material agreement, Agreement ended, New debt
Mar 2, 2026 Feb 27, 2026
S-8 Employee stock plan registration Feb 23, 2026 —
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 23, 2026 Feb 23, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
S-3ASR Automatic shelf registration Oct 28, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
8-K Current report
Officer or director change
Sep 18, 2025 Sep 17, 2025
EFFECT Filing Sep 10, 2025 —
POS AM Filing Sep 5, 2025 —
UPLOAD Letter from the SEC Jul 30, 2025 —
10-Q Quarterly report Jul 29, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
CORRESP Letter to the SEC Jul 16, 2025 —
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 18, 2025
UPLOAD Letter from the SEC Jun 18, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Dec 31, 2024
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 16, 2025 Apr 15, 2025
S-8 POS Filing Feb 20, 2025 —
S-8 POS Filing Feb 20, 2025 —
S-8 POS Filing Feb 20, 2025 —
S-8 Employee stock plan registration Feb 20, 2025 —
10-K Annual report Feb 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 18, 2025 Feb 18, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 2, 2025 Jan 2, 2025
10-Q Quarterly report Oct 29, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 29, 2024 Oct 29, 2024
10-Q Quarterly report Jul 30, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 30, 2024 Jul 30, 2024
8-K Current report
Shareholder vote results
Jun 24, 2024 Jun 20, 2024
424B5 Prospectus supplement Apr 30, 2024 —
8-K Current report
Material agreement
Apr 29, 2024 Apr 29, 2024
424B5 Prospectus supplement Apr 29, 2024 —
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Dec 31, 2023
10-Q Quarterly report Apr 29, 2024 Mar 31, 2024
8-K Current report
Results of operations
Apr 29, 2024 Apr 29, 2024
S-8 Employee stock plan registration Feb 26, 2024 —
10-K Annual report Feb 23, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 20, 2024 Feb 20, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale
Oct 30, 2023 Oct 27, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
S-8 Employee stock plan registration Aug 8, 2023 —
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change
Jul 24, 2023 Jul 21, 2023
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 14, 2023
DEFA14A Additional proxy material Jun 6, 2023 —
8-K Current report
Other events
May 22, 2023 May 18, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders May 8, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 Dec 31, 2022
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Apr 28, 2023 Apr 24, 2023
S-8 Employee stock plan registration Apr 25, 2023 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Apr 17, 2023 Apr 14, 2023
8-K Current report
Officer or director change
Apr 14, 2023 Apr 12, 2023
DEF 14A Proxy statement Mar 31, 2023 Apr 14, 2023
PRE 14A Preliminary proxy statement Mar 21, 2023 Apr 14, 2023
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 14, 2023 Mar 14, 2023
8-K Current report
Officer or director change
Feb 14, 2023 Feb 14, 2023
424B5 Prospectus supplement Jan 30, 2023 —
8-K Current report
Material agreement
Jan 30, 2023 Jan 26, 2023
424B5 Prospectus supplement Jan 30, 2023 —
424B5 Prospectus supplement Jan 26, 2023 —
8-K Current report
Regulation FD disclosure
Jan 12, 2023 Jan 12, 2023
S-8 Employee stock plan registration Jan 9, 2023 —
8-K Current report
Results of operations, Bylaw or fiscal year change, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Listing notice, Other events
Dec 30, 2022 Dec 28, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations, Exit or restructuring costs
Nov 14, 2022 Nov 11, 2022
EFFECT Filing Sep 7, 2022 —
EFFECT Filing Sep 7, 2022 —
424B3 Prospectus Sep 7, 2022 —
CORRESP Letter to the SEC Sep 2, 2022 —
CORRESP Letter to the SEC Sep 2, 2022 —
UPLOAD Letter from the SEC Aug 31, 2022 —
UPLOAD Letter from the SEC Aug 31, 2022 —
424B3 Prospectus Aug 26, 2022 —
424B3 Prospectus Aug 26, 2022 —
S-3 Shelf registration Aug 26, 2022 —
S-3 Shelf registration Aug 26, 2022 —
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Aug 26, 2022 Aug 25, 2022
424B3 Prospectus Aug 15, 2022 —
424B3 Prospectus Aug 15, 2022 —
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 15, 2022 Aug 15, 2022
424B3 Prospectus Jul 1, 2022 —
424B3 Prospectus Jul 1, 2022 —
8-K Current report
Officer or director change
Jul 1, 2022 Jun 27, 2022
424B3 Prospectus Jun 14, 2022 —
424B3 Prospectus Jun 14, 2022 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 14, 2022 Jun 10, 2022
424B3 Prospectus May 12, 2022 —
424B3 Prospectus May 12, 2022 —
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
EFFECT Filing May 11, 2022 —
424B3 Prospectus May 11, 2022 —
CORRESP Letter to the SEC May 9, 2022 —
UPLOAD Letter from the SEC May 5, 2022 —
S-8 Employee stock plan registration May 3, 2022 —
S-1 Registration statement May 3, 2022 —
424B3 Prospectus May 2, 2022 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
May 2, 2022 Apr 29, 2022
424B3 Prospectus Apr 27, 2022 —
8-K Current report
Shareholder vote results
Apr 27, 2022 Apr 27, 2022
DEFA14A Additional proxy material Apr 18, 2022 —
DEFM14A Filing Mar 31, 2022 —
424B3 Prospectus Mar 28, 2022 —
EFFECT Filing Mar 24, 2022 —
POS AM Filing Mar 21, 2022 —
424B3 Prospectus Mar 15, 2022 —
PREM14A Filing Mar 15, 2022 Mar 15, 2022
DEFA14A Additional proxy material Mar 15, 2022 —
424B3 Prospectus Mar 14, 2022 —
POS EX Filing Mar 14, 2022 —
10-K Annual report Mar 14, 2022 Dec 31, 2021
8-K Current report
Results of operations, Restatement
Mar 14, 2022 Mar 10, 2022
8-K Current report
Results of operations, Restatement
Mar 14, 2022 Mar 10, 2022
DEFA14A Additional proxy material Mar 14, 2022 —
DEFA14A Additional proxy material Mar 8, 2022 —
DEFA14A Additional proxy material Feb 22, 2022 —
DEFA14A Additional proxy material Feb 17, 2022 —
424B3 Prospectus Jan 31, 2022 —
8-K Current report
Officer or director change
Jan 31, 2022 Jan 25, 2022
S-8 Employee stock plan registration Jan 25, 2022 —
DEFA14A Additional proxy material Jan 18, 2022 —
DEFA14A Additional proxy material Jan 18, 2022 —
424B3 Prospectus Jan 18, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Jan 18, 2022 Jan 14, 2022
424B3 Prospectus Jan 10, 2022 —
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
424B3 Prospectus Jan 10, 2022 —
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Other events
Dec 16, 2021 Dec 15, 2021
424B3 Prospectus Nov 15, 2021 —
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
S-8 Employee stock plan registration Oct 25, 2021 —
424B3 Prospectus Oct 15, 2021 —
424B3 Prospectus Oct 15, 2021 —
8-K Current report
Officer or director change
Oct 14, 2021 Oct 8, 2021
S-8 Employee stock plan registration Sep 27, 2021 —
424B3 Prospectus Aug 17, 2021 —
8-K/A Amended current report
Acquisition or sale of assets
Aug 16, 2021 Jul 22, 2021
8-K Current report
Results of operations, Auditor change
Aug 16, 2021 Aug 13, 2021
EFFECT Filing Aug 12, 2021 —
424B3 Prospectus Aug 12, 2021 —
CORRESP Letter to the SEC Aug 10, 2021 —
UPLOAD Letter from the SEC Aug 10, 2021 —
S-1 Registration statement Aug 4, 2021 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
Jul 28, 2021 Jul 22, 2021
25-NSE Delisting notice Jul 23, 2021 —
8-K Current report
Shareholder vote results
Jul 22, 2021 Jul 21, 2021
10-Q Quarterly report Jul 21, 2021 Jun 30, 2021
8-K Current report
Other events
Jul 19, 2021 Jul 19, 2021
DEFA14A Additional proxy material Jul 19, 2021 —
UPLOAD Letter from the SEC Jul 2, 2021 —
CORRESP Letter to the SEC Jul 2, 2021 —
DEFM14A Filing Jul 2, 2021 —
UPLOAD Letter from the SEC Jul 1, 2021 —
CORRESP Letter to the SEC Jun 28, 2021 —
PRER14A Filing Jun 28, 2021 —
UPLOAD Letter from the SEC Jun 25, 2021 —
DEFA14A Additional proxy material Jun 11, 2021 —
DEFA14A Additional proxy material Jun 11, 2021 —
CORRESP Letter to the SEC Jun 10, 2021 —
PRER14A Filing Jun 10, 2021 —
UPLOAD Letter from the SEC Jun 2, 2021 —
10-Q Quarterly report May 24, 2021 Mar 31, 2021
NT 10-Q Notification of late filing May 18, 2021 Mar 31, 2021
425 Form 425 May 7, 2021 —
PREM14A Filing May 6, 2021 May 6, 2021
10-K/A Amended annual report May 5, 2021 Dec 31, 2020
425 Current report May 5, 2021 —
8-K Current report
Restatement
May 5, 2021 May 3, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
DEFA14A Additional proxy material Feb 12, 2021 —
8-K Current report
Material agreement, Unregistered share sale
Feb 11, 2021 Feb 11, 2021
DEFA14A Additional proxy material Feb 11, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
WGS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Stamford, CT
SEC filer status
Large accelerated filer
SEC CIK
1818331
Former names
Sema4 Holdings Corp. (until Jan 5, 2023); CM Life Sciences, Inc. (until Jul 21, 2021)

Other Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.